nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—ACE—psoriasis	0.579	1	CbGaD
Trandolapril—CES1—Mycophenolate mofetil—psoriasis	0.226	1	CbGbCtD
Trandolapril—Fosinopril—ACE—psoriasis	0.000743	0.117	CrCbGaD
Trandolapril—Perindopril—ACE—psoriasis	0.000606	0.0952	CrCbGaD
Trandolapril—Spirapril—ACE—psoriasis	0.000599	0.0942	CrCbGaD
Trandolapril—Moexipril—ACE—psoriasis	0.000574	0.0903	CrCbGaD
Trandolapril—Mitiglinide—PPARG—psoriasis	0.000572	0.0899	CrCbGaD
Trandolapril—Quinapril—ACE—psoriasis	0.000534	0.0839	CrCbGaD
Trandolapril—Cilazapril—ACE—psoriasis	0.000534	0.0839	CrCbGaD
Trandolapril—Lisinopril—ACE—psoriasis	0.000534	0.0839	CrCbGaD
Trandolapril—Ramipril—ACE—psoriasis	0.000517	0.0813	CrCbGaD
Trandolapril—Benazepril—ACE—psoriasis	0.000464	0.073	CrCbGaD
Trandolapril—Enalapril—ACE—psoriasis	0.000392	0.0616	CrCbGaD
Trandolapril—Nateglinide—PPARG—psoriasis	0.000291	0.0458	CrCbGaD
Trandolapril—Hyperhidrosis—Triamcinolone—psoriasis	7.63e-05	0.000405	CcSEcCtD
Trandolapril—Agranulocytosis—Methotrexate—psoriasis	7.63e-05	0.000404	CcSEcCtD
Trandolapril—Feeling abnormal—Mycophenolate mofetil—psoriasis	7.59e-05	0.000402	CcSEcCtD
Trandolapril—Insomnia—Hydrocortisone—psoriasis	7.59e-05	0.000402	CcSEcCtD
Trandolapril—Paraesthesia—Hydrocortisone—psoriasis	7.53e-05	0.000399	CcSEcCtD
Trandolapril—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	7.53e-05	0.000399	CcSEcCtD
Trandolapril—Urticaria—Cyclosporine—psoriasis	7.5e-05	0.000397	CcSEcCtD
Trandolapril—Myalgia—Betamethasone—psoriasis	7.48e-05	0.000396	CcSEcCtD
Trandolapril—Myalgia—Dexamethasone—psoriasis	7.48e-05	0.000396	CcSEcCtD
Trandolapril—Abdominal pain—Cyclosporine—psoriasis	7.46e-05	0.000395	CcSEcCtD
Trandolapril—Body temperature increased—Cyclosporine—psoriasis	7.46e-05	0.000395	CcSEcCtD
Trandolapril—Anxiety—Betamethasone—psoriasis	7.45e-05	0.000395	CcSEcCtD
Trandolapril—Anxiety—Dexamethasone—psoriasis	7.45e-05	0.000395	CcSEcCtD
Trandolapril—Vomiting—Mycophenolic acid—psoriasis	7.42e-05	0.000393	CcSEcCtD
Trandolapril—Discomfort—Betamethasone—psoriasis	7.39e-05	0.000391	CcSEcCtD
Trandolapril—Discomfort—Dexamethasone—psoriasis	7.39e-05	0.000391	CcSEcCtD
Trandolapril—Dyspepsia—Hydrocortisone—psoriasis	7.38e-05	0.000391	CcSEcCtD
Trandolapril—Rash—Mycophenolic acid—psoriasis	7.36e-05	0.00039	CcSEcCtD
Trandolapril—Dermatitis—Mycophenolic acid—psoriasis	7.35e-05	0.000389	CcSEcCtD
Trandolapril—Hepatitis—Methotrexate—psoriasis	7.34e-05	0.000389	CcSEcCtD
Trandolapril—Urticaria—Mycophenolate mofetil—psoriasis	7.31e-05	0.000387	CcSEcCtD
Trandolapril—Headache—Mycophenolic acid—psoriasis	7.31e-05	0.000387	CcSEcCtD
Trandolapril—Decreased appetite—Hydrocortisone—psoriasis	7.29e-05	0.000386	CcSEcCtD
Trandolapril—Pharyngitis—Methotrexate—psoriasis	7.29e-05	0.000386	CcSEcCtD
Trandolapril—Abdominal pain—Mycophenolate mofetil—psoriasis	7.28e-05	0.000386	CcSEcCtD
Trandolapril—Body temperature increased—Mycophenolate mofetil—psoriasis	7.28e-05	0.000386	CcSEcCtD
Trandolapril—Urinary tract disorder—Methotrexate—psoriasis	7.25e-05	0.000384	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Hydrocortisone—psoriasis	7.24e-05	0.000384	CcSEcCtD
Trandolapril—Fatigue—Hydrocortisone—psoriasis	7.23e-05	0.000383	CcSEcCtD
Trandolapril—Urethral disorder—Methotrexate—psoriasis	7.2e-05	0.000381	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Triamcinolone—psoriasis	7.2e-05	0.000381	CcSEcCtD
Trandolapril—Oedema—Dexamethasone—psoriasis	7.17e-05	0.00038	CcSEcCtD
Trandolapril—Oedema—Betamethasone—psoriasis	7.17e-05	0.00038	CcSEcCtD
Trandolapril—Insomnia—Triamcinolone—psoriasis	7.14e-05	0.000378	CcSEcCtD
Trandolapril—Infection—Betamethasone—psoriasis	7.12e-05	0.000377	CcSEcCtD
Trandolapril—Infection—Dexamethasone—psoriasis	7.12e-05	0.000377	CcSEcCtD
Trandolapril—Ill-defined disorder—Prednisone—psoriasis	7.09e-05	0.000376	CcSEcCtD
Trandolapril—Paraesthesia—Triamcinolone—psoriasis	7.09e-05	0.000376	CcSEcCtD
Trandolapril—Feeling abnormal—Prednisolone—psoriasis	7.08e-05	0.000375	CcSEcCtD
Trandolapril—Visual impairment—Methotrexate—psoriasis	7.07e-05	0.000375	CcSEcCtD
Trandolapril—Anaemia—Prednisone—psoriasis	7.07e-05	0.000374	CcSEcCtD
Trandolapril—Shock—Dexamethasone—psoriasis	7.05e-05	0.000374	CcSEcCtD
Trandolapril—Shock—Betamethasone—psoriasis	7.05e-05	0.000374	CcSEcCtD
Trandolapril—Dyspnoea—Triamcinolone—psoriasis	7.04e-05	0.000373	CcSEcCtD
Trandolapril—Nervous system disorder—Dexamethasone—psoriasis	7.03e-05	0.000372	CcSEcCtD
Trandolapril—Nervous system disorder—Betamethasone—psoriasis	7.03e-05	0.000372	CcSEcCtD
Trandolapril—Agitation—Prednisone—psoriasis	7.03e-05	0.000372	CcSEcCtD
Trandolapril—Thrombocytopenia—Dexamethasone—psoriasis	7.02e-05	0.000372	CcSEcCtD
Trandolapril—Thrombocytopenia—Betamethasone—psoriasis	7.02e-05	0.000372	CcSEcCtD
Trandolapril—Tachycardia—Betamethasone—psoriasis	6.99e-05	0.000371	CcSEcCtD
Trandolapril—Tachycardia—Dexamethasone—psoriasis	6.99e-05	0.000371	CcSEcCtD
Trandolapril—Angioedema—Prednisone—psoriasis	6.99e-05	0.00037	CcSEcCtD
Trandolapril—Hypersensitivity—Cyclosporine—psoriasis	6.95e-05	0.000368	CcSEcCtD
Trandolapril—Dyspepsia—Triamcinolone—psoriasis	6.95e-05	0.000368	CcSEcCtD
Trandolapril—Erythema multiforme—Methotrexate—psoriasis	6.94e-05	0.000368	CcSEcCtD
Trandolapril—Nausea—Mycophenolic acid—psoriasis	6.93e-05	0.000367	CcSEcCtD
Trandolapril—Hyperhidrosis—Dexamethasone—psoriasis	6.93e-05	0.000367	CcSEcCtD
Trandolapril—Hyperhidrosis—Betamethasone—psoriasis	6.93e-05	0.000367	CcSEcCtD
Trandolapril—Feeling abnormal—Hydrocortisone—psoriasis	6.91e-05	0.000366	CcSEcCtD
Trandolapril—Malaise—Prednisone—psoriasis	6.9e-05	0.000365	CcSEcCtD
Trandolapril—Vertigo—Prednisone—psoriasis	6.87e-05	0.000364	CcSEcCtD
Trandolapril—Eye disorder—Methotrexate—psoriasis	6.86e-05	0.000363	CcSEcCtD
Trandolapril—Gastrointestinal pain—Hydrocortisone—psoriasis	6.86e-05	0.000363	CcSEcCtD
Trandolapril—Syncope—Prednisone—psoriasis	6.86e-05	0.000363	CcSEcCtD
Trandolapril—Tinnitus—Methotrexate—psoriasis	6.84e-05	0.000363	CcSEcCtD
Trandolapril—Anorexia—Dexamethasone—psoriasis	6.83e-05	0.000362	CcSEcCtD
Trandolapril—Anorexia—Betamethasone—psoriasis	6.83e-05	0.000362	CcSEcCtD
Trandolapril—Urticaria—Prednisolone—psoriasis	6.82e-05	0.000361	CcSEcCtD
Trandolapril—Cardiac disorder—Methotrexate—psoriasis	6.81e-05	0.000361	CcSEcCtD
Trandolapril—Fatigue—Triamcinolone—psoriasis	6.81e-05	0.000361	CcSEcCtD
Trandolapril—Hypersensitivity—Mycophenolate mofetil—psoriasis	6.78e-05	0.000359	CcSEcCtD
Trandolapril—Asthenia—Cyclosporine—psoriasis	6.77e-05	0.000359	CcSEcCtD
Trandolapril—Loss of consciousness—Prednisone—psoriasis	6.72e-05	0.000356	CcSEcCtD
Trandolapril—Hypotension—Dexamethasone—psoriasis	6.7e-05	0.000355	CcSEcCtD
Trandolapril—Hypotension—Betamethasone—psoriasis	6.7e-05	0.000355	CcSEcCtD
Trandolapril—Pruritus—Cyclosporine—psoriasis	6.68e-05	0.000354	CcSEcCtD
Trandolapril—Urticaria—Hydrocortisone—psoriasis	6.66e-05	0.000353	CcSEcCtD
Trandolapril—Angiopathy—Methotrexate—psoriasis	6.66e-05	0.000353	CcSEcCtD
Trandolapril—Immune system disorder—Methotrexate—psoriasis	6.63e-05	0.000351	CcSEcCtD
Trandolapril—Abdominal pain—Hydrocortisone—psoriasis	6.63e-05	0.000351	CcSEcCtD
Trandolapril—Body temperature increased—Hydrocortisone—psoriasis	6.63e-05	0.000351	CcSEcCtD
Trandolapril—Mediastinal disorder—Methotrexate—psoriasis	6.62e-05	0.000351	CcSEcCtD
Trandolapril—Asthenia—Mycophenolate mofetil—psoriasis	6.61e-05	0.00035	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Betamethasone—psoriasis	6.53e-05	0.000346	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Dexamethasone—psoriasis	6.53e-05	0.000346	CcSEcCtD
Trandolapril—Pruritus—Mycophenolate mofetil—psoriasis	6.51e-05	0.000345	CcSEcCtD
Trandolapril—Myalgia—Prednisone—psoriasis	6.51e-05	0.000345	CcSEcCtD
Trandolapril—Arthralgia—Prednisone—psoriasis	6.51e-05	0.000345	CcSEcCtD
Trandolapril—Feeling abnormal—Triamcinolone—psoriasis	6.51e-05	0.000345	CcSEcCtD
Trandolapril—Anxiety—Prednisone—psoriasis	6.49e-05	0.000344	CcSEcCtD
Trandolapril—Alopecia—Methotrexate—psoriasis	6.49e-05	0.000344	CcSEcCtD
Trandolapril—Insomnia—Dexamethasone—psoriasis	6.48e-05	0.000343	CcSEcCtD
Trandolapril—Insomnia—Betamethasone—psoriasis	6.48e-05	0.000343	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	6.47e-05	0.000343	CcSEcCtD
Trandolapril—Diarrhoea—Cyclosporine—psoriasis	6.46e-05	0.000342	CcSEcCtD
Trandolapril—Paraesthesia—Dexamethasone—psoriasis	6.43e-05	0.000341	CcSEcCtD
Trandolapril—Paraesthesia—Betamethasone—psoriasis	6.43e-05	0.000341	CcSEcCtD
Trandolapril—Discomfort—Prednisone—psoriasis	6.43e-05	0.000341	CcSEcCtD
Trandolapril—Mental disorder—Methotrexate—psoriasis	6.43e-05	0.000341	CcSEcCtD
Trandolapril—Malnutrition—Methotrexate—psoriasis	6.39e-05	0.000339	CcSEcCtD
Trandolapril—Hypersensitivity—Prednisolone—psoriasis	6.33e-05	0.000335	CcSEcCtD
Trandolapril—Dyspepsia—Dexamethasone—psoriasis	6.31e-05	0.000334	CcSEcCtD
Trandolapril—Dyspepsia—Betamethasone—psoriasis	6.31e-05	0.000334	CcSEcCtD
Trandolapril—Diarrhoea—Mycophenolate mofetil—psoriasis	6.3e-05	0.000334	CcSEcCtD
Trandolapril—Urticaria—Triamcinolone—psoriasis	6.27e-05	0.000332	CcSEcCtD
Trandolapril—Dysgeusia—Methotrexate—psoriasis	6.26e-05	0.000332	CcSEcCtD
Trandolapril—Body temperature increased—Triamcinolone—psoriasis	6.24e-05	0.000331	CcSEcCtD
Trandolapril—Dizziness—Cyclosporine—psoriasis	6.24e-05	0.000331	CcSEcCtD
Trandolapril—Oedema—Prednisone—psoriasis	6.24e-05	0.000331	CcSEcCtD
Trandolapril—Decreased appetite—Betamethasone—psoriasis	6.23e-05	0.00033	CcSEcCtD
Trandolapril—Decreased appetite—Dexamethasone—psoriasis	6.23e-05	0.00033	CcSEcCtD
Trandolapril—Infection—Prednisone—psoriasis	6.2e-05	0.000328	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Betamethasone—psoriasis	6.19e-05	0.000328	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Dexamethasone—psoriasis	6.19e-05	0.000328	CcSEcCtD
Trandolapril—Back pain—Methotrexate—psoriasis	6.18e-05	0.000327	CcSEcCtD
Trandolapril—Hypersensitivity—Hydrocortisone—psoriasis	6.18e-05	0.000327	CcSEcCtD
Trandolapril—Fatigue—Dexamethasone—psoriasis	6.18e-05	0.000327	CcSEcCtD
Trandolapril—Fatigue—Betamethasone—psoriasis	6.18e-05	0.000327	CcSEcCtD
Trandolapril—Shock—Prednisone—psoriasis	6.14e-05	0.000325	CcSEcCtD
Trandolapril—Nervous system disorder—Prednisone—psoriasis	6.12e-05	0.000324	CcSEcCtD
Trandolapril—Tachycardia—Prednisone—psoriasis	6.09e-05	0.000323	CcSEcCtD
Trandolapril—Dizziness—Mycophenolate mofetil—psoriasis	6.09e-05	0.000323	CcSEcCtD
Trandolapril—Skin disorder—Prednisone—psoriasis	6.06e-05	0.000321	CcSEcCtD
Trandolapril—Hyperhidrosis—Prednisone—psoriasis	6.03e-05	0.00032	CcSEcCtD
Trandolapril—Asthenia—Hydrocortisone—psoriasis	6.02e-05	0.000319	CcSEcCtD
Trandolapril—Vomiting—Cyclosporine—psoriasis	6e-05	0.000318	CcSEcCtD
Trandolapril—Rash—Cyclosporine—psoriasis	5.95e-05	0.000315	CcSEcCtD
Trandolapril—Anorexia—Prednisone—psoriasis	5.95e-05	0.000315	CcSEcCtD
Trandolapril—Dermatitis—Cyclosporine—psoriasis	5.95e-05	0.000315	CcSEcCtD
Trandolapril—Pruritus—Hydrocortisone—psoriasis	5.93e-05	0.000314	CcSEcCtD
Trandolapril—Ill-defined disorder—Methotrexate—psoriasis	5.93e-05	0.000314	CcSEcCtD
Trandolapril—Headache—Cyclosporine—psoriasis	5.91e-05	0.000313	CcSEcCtD
Trandolapril—Anaemia—Methotrexate—psoriasis	5.91e-05	0.000313	CcSEcCtD
Trandolapril—Feeling abnormal—Betamethasone—psoriasis	5.91e-05	0.000313	CcSEcCtD
Trandolapril—Feeling abnormal—Dexamethasone—psoriasis	5.91e-05	0.000313	CcSEcCtD
Trandolapril—Gastrointestinal pain—Betamethasone—psoriasis	5.86e-05	0.00031	CcSEcCtD
Trandolapril—Gastrointestinal pain—Dexamethasone—psoriasis	5.86e-05	0.00031	CcSEcCtD
Trandolapril—Vomiting—Mycophenolate mofetil—psoriasis	5.85e-05	0.00031	CcSEcCtD
Trandolapril—Hypersensitivity—Triamcinolone—psoriasis	5.82e-05	0.000308	CcSEcCtD
Trandolapril—Rash—Mycophenolate mofetil—psoriasis	5.8e-05	0.000308	CcSEcCtD
Trandolapril—Dermatitis—Mycophenolate mofetil—psoriasis	5.8e-05	0.000307	CcSEcCtD
Trandolapril—Headache—Mycophenolate mofetil—psoriasis	5.77e-05	0.000306	CcSEcCtD
Trandolapril—Malaise—Methotrexate—psoriasis	5.76e-05	0.000305	CcSEcCtD
Trandolapril—Vertigo—Methotrexate—psoriasis	5.74e-05	0.000304	CcSEcCtD
Trandolapril—Diarrhoea—Hydrocortisone—psoriasis	5.74e-05	0.000304	CcSEcCtD
Trandolapril—Leukopenia—Methotrexate—psoriasis	5.72e-05	0.000303	CcSEcCtD
Trandolapril—Urticaria—Dexamethasone—psoriasis	5.69e-05	0.000302	CcSEcCtD
Trandolapril—Urticaria—Betamethasone—psoriasis	5.69e-05	0.000302	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Prednisone—psoriasis	5.69e-05	0.000301	CcSEcCtD
Trandolapril—Dizziness—Prednisolone—psoriasis	5.68e-05	0.000301	CcSEcCtD
Trandolapril—Asthenia—Triamcinolone—psoriasis	5.67e-05	0.0003	CcSEcCtD
Trandolapril—Abdominal pain—Dexamethasone—psoriasis	5.66e-05	0.0003	CcSEcCtD
Trandolapril—Body temperature increased—Betamethasone—psoriasis	5.66e-05	0.0003	CcSEcCtD
Trandolapril—Body temperature increased—Dexamethasone—psoriasis	5.66e-05	0.0003	CcSEcCtD
Trandolapril—Abdominal pain—Betamethasone—psoriasis	5.66e-05	0.0003	CcSEcCtD
Trandolapril—Insomnia—Prednisone—psoriasis	5.64e-05	0.000299	CcSEcCtD
Trandolapril—Nausea—Cyclosporine—psoriasis	5.61e-05	0.000297	CcSEcCtD
Trandolapril—Paraesthesia—Prednisone—psoriasis	5.6e-05	0.000297	CcSEcCtD
Trandolapril—Pruritus—Triamcinolone—psoriasis	5.59e-05	0.000296	CcSEcCtD
Trandolapril—Cough—Methotrexate—psoriasis	5.58e-05	0.000295	CcSEcCtD
Trandolapril—Dizziness—Hydrocortisone—psoriasis	5.55e-05	0.000294	CcSEcCtD
Trandolapril—Dyspepsia—Prednisone—psoriasis	5.49e-05	0.000291	CcSEcCtD
Trandolapril—Nausea—Mycophenolate mofetil—psoriasis	5.47e-05	0.00029	CcSEcCtD
Trandolapril—Arthralgia—Methotrexate—psoriasis	5.44e-05	0.000288	CcSEcCtD
Trandolapril—Chest pain—Methotrexate—psoriasis	5.44e-05	0.000288	CcSEcCtD
Trandolapril—Myalgia—Methotrexate—psoriasis	5.44e-05	0.000288	CcSEcCtD
Trandolapril—Decreased appetite—Prednisone—psoriasis	5.42e-05	0.000287	CcSEcCtD
Trandolapril—Rash—Prednisolone—psoriasis	5.41e-05	0.000287	CcSEcCtD
Trandolapril—Dermatitis—Prednisolone—psoriasis	5.41e-05	0.000287	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	5.4e-05	0.000286	CcSEcCtD
Trandolapril—Fatigue—Prednisone—psoriasis	5.38e-05	0.000285	CcSEcCtD
Trandolapril—Headache—Prednisolone—psoriasis	5.38e-05	0.000285	CcSEcCtD
Trandolapril—Discomfort—Methotrexate—psoriasis	5.38e-05	0.000285	CcSEcCtD
Trandolapril—Constipation—Prednisone—psoriasis	5.34e-05	0.000283	CcSEcCtD
Trandolapril—Vomiting—Hydrocortisone—psoriasis	5.33e-05	0.000283	CcSEcCtD
Trandolapril—Rash—Hydrocortisone—psoriasis	5.29e-05	0.00028	CcSEcCtD
Trandolapril—Dermatitis—Hydrocortisone—psoriasis	5.28e-05	0.00028	CcSEcCtD
Trandolapril—Headache—Hydrocortisone—psoriasis	5.25e-05	0.000278	CcSEcCtD
Trandolapril—Dizziness—Triamcinolone—psoriasis	5.22e-05	0.000277	CcSEcCtD
Trandolapril—Infection—Methotrexate—psoriasis	5.18e-05	0.000275	CcSEcCtD
Trandolapril—Feeling abnormal—Prednisone—psoriasis	5.14e-05	0.000272	CcSEcCtD
Trandolapril—Asthenia—Betamethasone—psoriasis	5.14e-05	0.000272	CcSEcCtD
Trandolapril—Asthenia—Dexamethasone—psoriasis	5.14e-05	0.000272	CcSEcCtD
Trandolapril—Nervous system disorder—Methotrexate—psoriasis	5.11e-05	0.000271	CcSEcCtD
Trandolapril—Thrombocytopenia—Methotrexate—psoriasis	5.11e-05	0.000271	CcSEcCtD
Trandolapril—Gastrointestinal pain—Prednisone—psoriasis	5.1e-05	0.00027	CcSEcCtD
Trandolapril—Nausea—Prednisolone—psoriasis	5.1e-05	0.00027	CcSEcCtD
Trandolapril—Pruritus—Dexamethasone—psoriasis	5.07e-05	0.000269	CcSEcCtD
Trandolapril—Pruritus—Betamethasone—psoriasis	5.07e-05	0.000269	CcSEcCtD
Trandolapril—Skin disorder—Methotrexate—psoriasis	5.07e-05	0.000268	CcSEcCtD
Trandolapril—Hyperhidrosis—Methotrexate—psoriasis	5.04e-05	0.000267	CcSEcCtD
Trandolapril—Vomiting—Triamcinolone—psoriasis	5.02e-05	0.000266	CcSEcCtD
Trandolapril—Nausea—Hydrocortisone—psoriasis	4.98e-05	0.000264	CcSEcCtD
Trandolapril—Rash—Triamcinolone—psoriasis	4.98e-05	0.000264	CcSEcCtD
Trandolapril—Dermatitis—Triamcinolone—psoriasis	4.98e-05	0.000264	CcSEcCtD
Trandolapril—Anorexia—Methotrexate—psoriasis	4.97e-05	0.000263	CcSEcCtD
Trandolapril—Urticaria—Prednisone—psoriasis	4.96e-05	0.000263	CcSEcCtD
Trandolapril—Headache—Triamcinolone—psoriasis	4.95e-05	0.000262	CcSEcCtD
Trandolapril—Body temperature increased—Prednisone—psoriasis	4.93e-05	0.000261	CcSEcCtD
Trandolapril—Abdominal pain—Prednisone—psoriasis	4.93e-05	0.000261	CcSEcCtD
Trandolapril—Diarrhoea—Betamethasone—psoriasis	4.9e-05	0.00026	CcSEcCtD
Trandolapril—Diarrhoea—Dexamethasone—psoriasis	4.9e-05	0.00026	CcSEcCtD
Trandolapril—Hypotension—Methotrexate—psoriasis	4.87e-05	0.000258	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Methotrexate—psoriasis	4.75e-05	0.000252	CcSEcCtD
Trandolapril—Dizziness—Dexamethasone—psoriasis	4.74e-05	0.000251	CcSEcCtD
Trandolapril—Dizziness—Betamethasone—psoriasis	4.74e-05	0.000251	CcSEcCtD
Trandolapril—Insomnia—Methotrexate—psoriasis	4.72e-05	0.00025	CcSEcCtD
Trandolapril—Nausea—Triamcinolone—psoriasis	4.69e-05	0.000249	CcSEcCtD
Trandolapril—Paraesthesia—Methotrexate—psoriasis	4.68e-05	0.000248	CcSEcCtD
Trandolapril—Dyspnoea—Methotrexate—psoriasis	4.65e-05	0.000246	CcSEcCtD
Trandolapril—Somnolence—Methotrexate—psoriasis	4.64e-05	0.000246	CcSEcCtD
Trandolapril—Hypersensitivity—Prednisone—psoriasis	4.6e-05	0.000244	CcSEcCtD
Trandolapril—Dyspepsia—Methotrexate—psoriasis	4.59e-05	0.000243	CcSEcCtD
Trandolapril—Vomiting—Betamethasone—psoriasis	4.56e-05	0.000241	CcSEcCtD
Trandolapril—Vomiting—Dexamethasone—psoriasis	4.56e-05	0.000241	CcSEcCtD
Trandolapril—Decreased appetite—Methotrexate—psoriasis	4.53e-05	0.00024	CcSEcCtD
Trandolapril—Rash—Dexamethasone—psoriasis	4.52e-05	0.000239	CcSEcCtD
Trandolapril—Rash—Betamethasone—psoriasis	4.52e-05	0.000239	CcSEcCtD
Trandolapril—Dermatitis—Dexamethasone—psoriasis	4.51e-05	0.000239	CcSEcCtD
Trandolapril—Dermatitis—Betamethasone—psoriasis	4.51e-05	0.000239	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Methotrexate—psoriasis	4.5e-05	0.000239	CcSEcCtD
Trandolapril—Fatigue—Methotrexate—psoriasis	4.5e-05	0.000238	CcSEcCtD
Trandolapril—Headache—Dexamethasone—psoriasis	4.49e-05	0.000238	CcSEcCtD
Trandolapril—Headache—Betamethasone—psoriasis	4.49e-05	0.000238	CcSEcCtD
Trandolapril—Asthenia—Prednisone—psoriasis	4.48e-05	0.000237	CcSEcCtD
Trandolapril—Pruritus—Prednisone—psoriasis	4.42e-05	0.000234	CcSEcCtD
Trandolapril—Feeling abnormal—Methotrexate—psoriasis	4.3e-05	0.000228	CcSEcCtD
Trandolapril—Diarrhoea—Prednisone—psoriasis	4.27e-05	0.000226	CcSEcCtD
Trandolapril—Gastrointestinal pain—Methotrexate—psoriasis	4.26e-05	0.000226	CcSEcCtD
Trandolapril—Nausea—Dexamethasone—psoriasis	4.26e-05	0.000226	CcSEcCtD
Trandolapril—Nausea—Betamethasone—psoriasis	4.26e-05	0.000226	CcSEcCtD
Trandolapril—Urticaria—Methotrexate—psoriasis	4.14e-05	0.00022	CcSEcCtD
Trandolapril—Dizziness—Prednisone—psoriasis	4.13e-05	0.000219	CcSEcCtD
Trandolapril—Body temperature increased—Methotrexate—psoriasis	4.12e-05	0.000218	CcSEcCtD
Trandolapril—Abdominal pain—Methotrexate—psoriasis	4.12e-05	0.000218	CcSEcCtD
Trandolapril—Vomiting—Prednisone—psoriasis	3.97e-05	0.00021	CcSEcCtD
Trandolapril—Rash—Prednisone—psoriasis	3.93e-05	0.000208	CcSEcCtD
Trandolapril—Dermatitis—Prednisone—psoriasis	3.93e-05	0.000208	CcSEcCtD
Trandolapril—Headache—Prednisone—psoriasis	3.91e-05	0.000207	CcSEcCtD
Trandolapril—Hypersensitivity—Methotrexate—psoriasis	3.84e-05	0.000204	CcSEcCtD
Trandolapril—Asthenia—Methotrexate—psoriasis	3.74e-05	0.000198	CcSEcCtD
Trandolapril—Nausea—Prednisone—psoriasis	3.71e-05	0.000196	CcSEcCtD
Trandolapril—Pruritus—Methotrexate—psoriasis	3.69e-05	0.000195	CcSEcCtD
Trandolapril—Diarrhoea—Methotrexate—psoriasis	3.57e-05	0.000189	CcSEcCtD
Trandolapril—Dizziness—Methotrexate—psoriasis	3.45e-05	0.000183	CcSEcCtD
Trandolapril—Vomiting—Methotrexate—psoriasis	3.32e-05	0.000176	CcSEcCtD
Trandolapril—Rash—Methotrexate—psoriasis	3.29e-05	0.000174	CcSEcCtD
Trandolapril—Dermatitis—Methotrexate—psoriasis	3.29e-05	0.000174	CcSEcCtD
Trandolapril—Headache—Methotrexate—psoriasis	3.27e-05	0.000173	CcSEcCtD
Trandolapril—Nausea—Methotrexate—psoriasis	3.1e-05	0.000164	CcSEcCtD
